Advanced search
Publication Cover
Expert Review of Vaccines Volume 9, 2010 - Issue 11
Submit an article Journal homepage
195
Views
44
CrossRef citations to date
0
Altmetric
Review

Use of attenuated paramyxoviruses for cancer therapy

Patrycja J Lech Mayo Clinic, Department of Molecular Medicine, 200 1st Street SW, Rochester, MN 55905, USA;[email protected]
&
Stephen J Russell Mayo Clinic, Department of Molecular Medicine, 200 1st Street SW, Rochester, MN 55905, USA; Mayo Clinic, Department of Molecular Medicine, 200 1st Street SW, Rochester, MN 55905, USA
Pages 1275-1302 | Published online: 09 Jan 2014

Citations (44)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ho Anh Son, LiFeng Zhang, Bui Khac Cuong, Hoang Van Tong, Le Duy Cuong, Ngo Thu Hang, Hoang Thi My Nhung, Naoki Yamamoto & Nguyen Linh Toan. (2018) Combination of Vaccine-Strain Measles and Mumps Viruses Enhances Oncolytic Activity against Human Solid Malignancies. Cancer Investigation 36:2, pages 106-117.
Read now

Articles from other publishers (43)

Nadia Ghasemi Darestani, Anna I. Gilmanova, Moaed E. Al-Gazally, Angelina O. Zekiy, Mohammad Javed Ansari, Rahman S. Zabibah, Mohammed Abed Jawad, Saif A. J. Al-Shalah, Jasur Alimdjanovich Rizaev, Yasir S. Alnassar, Naseer Mihdi Mohammed, Yasser Fakri Mustafa, Mohammad Darvishi & Reza Akhavan-Sigari. (2023) Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment. Cell Communication and Signaling 21:1.
Crossref
Madhu Gupta, Abhishek Wahi, Priyanka Sharma, Riya Nagpal, Neha Raina, Monika Kaurav, Jaydeep Bhattacharya, Sonia M. Rodrigues Oliveira, Karma G. Dolma, Alok K. Paul, Maria de Lourdes Pereira, Polrat Wilairatana, Mohammed Rahmatullah & Veeranoot Nissapatorn. (2022) Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects. Vaccines 10:12, pages 2011.
Crossref
Brenna Sharp, Ramya Rallabandi & Patricia Devaux. (2022) Advances in RNA Viral Vector Technology to Reprogram Somatic Cells: The Paramyxovirus Wave. Molecular Diagnosis & Therapy 26:4, pages 353-367.
Crossref
Chao Tang, Lan Li, Tong Mo, Jintong Na, Zhangbo Qian, Dianfa Fan, Xinjun Sun, Min Yao, Lina Pan, Yong Huang & Liping Zhong. (2022) Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical. Clinical and Translational Oncology 24:9, pages 1682-1701.
Crossref
Mary E. Carter, Andreas D. Hartkopf, Anna Wagner, Léa L. Volmer, Sara Y. Brucker, Susanne Berchtold, Ulrich M. Lauer & André Koch. (2022) A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy. Frontiers in Molecular Biosciences 9.
Crossref
Yao Lv, Chu-di Zhang, Yi-long Wang, Dong-ming Zhou, Meng-ying Zhu, Xiao-qiang Hao, Jin-hu Wang, Wei-zhong Gu, Hong-qiang Shen, Jin-gan Lou, Ben-qing Wu, Pei-chun Chen & Zheng-yan Zhao. (2021) Synergism of rMV-Hu191 with cisplatin to treat gastric cancer by acid sphingomyelinase-mediated apoptosis requiring integrity of lipid raft microdomains. Gastric Cancer 24:6, pages 1293-1306.
Crossref
Yu Chen, Shanshan Zhu, Yuru Pei, Jiao Hu, Zenglei Hu, Xiaowen Liu, Xiaoquan Wang, Min Gu, Shunlin Hu & Xiufan Liu. (2021) Differential microRNA Expression in Newcastle Disease Virus-Infected HeLa Cells and Its Role in Regulating Virus Replication. Frontiers in Oncology 11.
Crossref
Behnam Alirezaie, Ashraf Mohammadi, Arash Ghalyanchi Langeroudi, Roozbeh Fallahi & Ali Reza Khosravi. (2020) Intrinsic Oncolytic Activity of Hoshino Mumps Virus Vaccine Strain Against Human Fibrosarcoma and Cervical Cancer Cell Lines. International Journal of Cancer Management 13:9.
Crossref
Mohsen Keshavarz, Farid Solaymani-Mohammadi, Seyed Mohammad Miri & Amir Ghaemi. (2019) Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy. Journal of Biomedical Science 26:1.
Crossref
Schirrmacher, van Gool & Stuecker. (2019) Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy. Biomedicines 7:3, pages 66.
Crossref
Steven Dow & Amanda Guth. 2019. Withrow and MacEwen's Small Animal Clinical Oncology. Withrow and MacEwen's Small Animal Clinical Oncology 231 250 .
Y. I. Ammour, O. O. Ryabaya, A. V. Milovanova, A. V. Sidorov, I. E. Shohin, V. V. Zverev & T. V. Nasedkina. (2018) Oncolytic Properties of a Mumps Virus Vaccine Strain in Human Melanoma Cell Lines. Molecular Biology 52:4, pages 570-576.
Crossref
Teresa Nguyen, Naze Avci, Dong Shin, Naiara Martinez-Velez & Hong Jiang. (2018) Tune Up In Situ Autovaccination against Solid Tumors with Oncolytic Viruses. Cancers 10:6, pages 171.
Crossref
O. V. Matveeva, G. V. Kochneva, S. S. Zainutdinov, G. V. Ilyinskaya & P. M. Chumakov. (2018) Oncolytic Paramyxoviruses: Mechanism of Action, Preclinical and Clinical Studies. Molecular Biology 52:3, pages 306-322.
Crossref
Diane E. Griffin. (2018) Measles Vaccine. Viral Immunology 31:2, pages 86-95.
Crossref
Evidio Domingo-Musibay & Masato Yamamoto. (2016) Gene and virotherapy for hematological malignancies. International Journal of Hematology 104:1, pages 29-41.
Crossref
U Kumar & S Kumar. (2015) Molecular characterization of an apoptotic strain of Newcastle disease virus isolated from an outbreak in India. Cancer Gene Therapy 22:8, pages 402-409.
Crossref
Olga V Matveeva, Zong S Guo, Vyacheslav M Senin, Anna V Senina, Svetlana A Shabalina & Peter M Chumakov. (2015) Oncolysis by paramyxoviruses: preclinical and clinical studies. Molecular Therapy - Oncolytics 2, pages 15017.
Crossref
Volker Schirrmacher & Philippe Fournier. (2014) Multimodal Cancer Therapy Involving Oncolytic Newcastle Disease Virus, Autologous Immune Cells, and Bi-Specific Antibodies. Frontiers in Oncology 4.
Crossref
Can YurttasSusanne BerchtoldNisar P. MalekMichael BitzerUlrich M. Lauer. (2014) Pulsed Versus Continuous Application of the Prodrug 5-Fluorocytosine to Enhance the Oncolytic Effectiveness of a Measles Vaccine Virus Armed with a Suicide Gene. Human Gene Therapy Clinical Development 25:2, pages 85-96.
Crossref
András Balogh, Judit Bátor, Lajos Markó, Mária Németh, Marianna Pap, György SétálóJr.Jr., Dominik N. Müller, Laszlo K. Csatary & József Szeberényi. (2014) Gene expression profiling in PC12 cells infected with an oncolytic Newcastle disease virus strain. Virus Research 185, pages 10-22.
Crossref
Can Yurttas, Susanne Berchtold, Nisar Malek, Michael Bitzer & Ulrich M. Lauer. (2014) “PULSED” versus “CONTINUOUS” application of the prodrug 5-FC for enhancing oncolytic effectiveness of a measles vaccine virus armed with a suicide gene. Human Gene Therapy Clinical Development, pages 150127063140004.
Crossref
Martina Zimmermann, Sorin Armeanu-Ebinger, Sascha Bossow, Johanna Lampe, Irina Smirnow, Andrea Schenk, Sebastian Lange, Thomas S. Weiss, Wolfgang Neubert, Ulrich M. Lauer & Michael Bitzer. (2014) Attenuated and Protease-Profile Modified Sendai Virus Vectors as a New Tool for Virotherapy of Solid Tumors. PLoS ONE 9:3, pages e90508.
Crossref
Yu-Ping Liu, Samuel P. Russell, Camilo Ayala-Breton, Stephen J. Russell & Kah-Whye Peng. (2014) Ablation of Nectin4 Binding Compromises CD46 Usage by a Hybrid Vesicular Stomatitis Virus/Measles Virus. Journal of Virology 88:4, pages 2195-2204.
Crossref
Emily K Mader, Greg Butler, Sean C Dowdy, Andrea Mariani, Keith L Knutson, Mark J Federspiel, Stephen J Russell, Evanthia Galanis, Allan B Dietz & Kah-Whye Peng. (2013) Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer. Journal of Translational Medicine 11:1.
Crossref
J Lampe, S Bossow, T Weiland, I Smirnow, R Lehmann, W Neubert, M Bitzer & U M Lauer. (2013) An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis. Gene Therapy 20:11, pages 1033-1041.
Crossref
Chunsheng Liu, Lukkana Suksanpaisan, Yun-Wen Chen, Stephen J. Russell & Kah-Whye Peng. (2013) Enhancing cytokine-induced killer cell therapy of multiple myeloma. Experimental Hematology 41:6, pages 508-517.
Crossref
Sebastian LangeJohanna LampeSascha BossowMartina ZimmermannWolfgang NeubertMichael BitzerUlrich M. Lauer. (2013) A Novel Armed Oncolytic Measles Vaccine Virus for the Treatment of Cholangiocarcinoma. Human Gene Therapy 24:5, pages 554-564.
Crossref
Hui-fan Ji, Bao-rong Chi, Dong-yun He, Chang Li, Ning-ning Hu, Kai Wang, Yuan Sheng, Hong-yu Wang & Ning-yi Jin. (2013) Antitumor effects of Newcastle disease virus hemagglutinin-neuraminidase used as a molecular adjuvant. Chemical Research in Chinese Universities 29:2, pages 270-274.
Crossref
Susanne Berchtold, Johanna Lampe, Timo Weiland, Irina Smirnow, Sabine Schleicher, Rupert Handgretinger, Hans-Georg Kopp, Jeanette Reiser, Frank Stubenrauch, Nora Mayer, Nisar P. Malek, Michael Bitzer & Ulrich M. Lauer. (2013) Innate Immune Defense Defines Susceptibility of Sarcoma Cells to Measles Vaccine Virus-Based Oncolysis. Journal of Virology 87:6, pages 3484-3501.
Crossref
Iris VölkerPatricia BachCheick CoulibalyRoland PleskerTobias AbelJanna SeifriedSabine HeidmeierMichael D. MühlebachUlrich M. LauerChristian J. Buchholz. (2013) Intrahepatic Application of Suicide Gene-Armed Measles Virotherapeutics: A Safety Study in Transgenic Mice and Rhesus Macaques. Human Gene Therapy Clinical Development 24:1, pages 11-22.
Crossref
Patricia Bach, Tobias Abel, Christopher Hoffmann, Zoltan Gal, Gundula Braun, Iris Voelker, Claudia R. Ball, Ian C.D. Johnston, Ulrich M. Lauer, Christel Herold-Mende, Michael D. Mühlebach, Hanno Glimm & Christian J. Buchholz. (2013) Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus. Cancer Research 73:2, pages 865-874.
Crossref
Nicolas Boisgerault, Jean-Baptiste Guillerme, Daniel Pouliquen, Mariana Mesel-Lemoine, Carole Achard, Chantal Combredet, Jean-François Fonteneau, Frédéric Tangy & Marc Grégoire. (2013) Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas. BioMed Research International 2013, pages 1-11.
Crossref
Amanda M. Guth & Steven Dow. 2013. Withrow and MacEwen's Small Animal Clinical Oncology. Withrow and MacEwen's Small Animal Clinical Oncology 198 214 .
Alexander Ghanem & Karl‐Klaus Conzelmann. 2012. Reverse Genetics of RNA Viruses. Reverse Genetics of RNA Viruses 113 149 .
Azam Bolhassani & Farnaz Zahedifard. (2012) Therapeutic live vaccines as a potential anticancer strategy. International Journal of Cancer 131:8, pages 1733-1743.
Crossref
Ryan S. Noyce & Christopher D. Richardson. (2012) Nectin 4 is the epithelial cell receptor for measles virus. Trends in Microbiology 20:9, pages 429-439.
Crossref
Maria Cristina Galli. (2012) Long‐term follow‐up of cancer patients treated with gene therapy medicinal products. The Journal of Gene Medicine 14:6, pages 440-442.
Crossref
Camilo Ayala-BretonGlen N. BarberStephen J. RussellKah-Whye Peng. (2012) Retargeting Vesicular Stomatitis Virus Using Measles Virus Envelope Glycoproteins. Human Gene Therapy 23:5, pages 484-491.
Crossref
Dmitriy ZamarinPeter Palese. (2012) Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions. Future Microbiology 7:3, pages 347-367.
Crossref
Y-P Liu, C Tong, A Dispenzieri, M J Federspiel, S J Russell & K-W Peng. (2011) Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus. Cancer Gene Therapy 19:3, pages 202-211.
Crossref
M. H. Verheije & P. J. M. Rottier. (2012) Retargeting of Viruses to Generate Oncolytic Agents. Advances in Virology 2012, pages 1-15.
Crossref
Cecilia Larocca & Jeffrey Schlom. (2011) Viral Vector-Based Therapeutic Cancer Vaccines. The Cancer Journal 17:5, pages 359-371.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.